Mullerian Mucinous/Mixed Epithelial (Seromucinous) Ovarian Tumors

AJSP: Reviews and Reports

Volumn 21, Issue 5, 2016, Pages 206-213

  Rutgers, Joanne K L ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

borderline; mixed epithelial; mucinous; Mullerian; seromucinous

Indexed keywords

EID: 85017423755     PISSN: 23815949     EISSN: 2381652X     Source Type: Journal    
DOI: 10.1097/PCR.0000000000000155     Document Type: Article

References (87)

1. Rutgers JL, Scully RE,. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis. Cancer 1988; 61 (2): 340-348.
2. Rutgers JL, Scully RE,. Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of mullerian type. A clinicopathologic analysis. Cancer 1988; 61 (3): 546-554.
3. Tavassoli FADP,. Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2003.
4. Shappell HW, Riopel MA, Smith Sehdev AE, Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Am J Surg Pathol 2002; 26 (12): 1529-1541.
5. Hendrickson MR, Kempson RL,. Well-differentiated mucinous neoplasms of the ovary. Pathology (Phila) 1993; 1 (2): 307-334.
6. Kurman RJ, International Agency for Research on Cancer, World Health Organization. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon: International Agency for Research on Cancer; 2014.
7. Kurman RJ, Shih IeM,. Seromucinous tumors of the ovary. What's in a name? Int J Gynecol Pathol 2016; 35 (1): 78-81.
8. Rutgers JK,. Müllerian mucinous borderline tumors. Hum Pathol 2010; 41 (1): 151. author reply 151-152.
9. Baird DB, Reddick RL,. Extraovarian mucinous metaplasia in a patient with bilateral mucinous borderline ovarian tumors: a case report. Int J Gynecol Pathol 1991; 10 (1): 96-103.
10. Dube V, Roy M, Plante M, Mucinous ovarian tumors of Mullerian-type: an analysis of 17 cases including borderline tumors and intraepithelial, microinvasive, and invasive carcinomas. Int J Gynecol Pathol 2005; 24 (2): 138-146.
11. Guerrieri C, Boeryd B, Höberg T, Mucinous borderline and malignant tumors of the ovary. A clinicopathologic and DNA ploidy study of 92 cases. Cancer 1994; 74 (8): 2329-2340.
12. Hamada T, Kiyokawa T, Nomura K, Immunohistochemical analysis of reserve cell-like cells of ovarian müllerian mucinous/mixed epithelial borderline tumor. Int J Gynecol Pathol 2008; 27 (2): 199-206.
13. Khunamornpong S, Russell P, Dalrymple JC,. Proliferating (LMP) mucinous tumors of the ovaries with microinvasion: morphologic assessment of 13 cases. Int J Gynecol Pathol 1999; 18 (3): 238-246.
14. Kim KR, Choi J, Hwang JE, Endocervical-like (Müllerian) mucinous borderline tumours of the ovary are frequently associated with the KRAS mutation. Histopathology 2010; 57 (4): 587-596.
15. Measham C, Rutgers JL,. Abdominal wall implantation of an endocervical-like mucinous borderline tumor. Mod Pathol 1996; 9 (4): 381-385.
16. Moriya T, Mikami Y, Sakamoto K, Endocervical-like mucinous borderline tumors of the ovary: clinicopathological features and electron microscopic findings. Med Electron Microsc 2003; 36 (4): 240-246.
17. Nagai Y, Kishimoto T, Nikaido T, Squamous predominance in mixed-epithelial papillary cystadenomas of borderline malignancy of mullerian type arising in endometriotic cysts: a study of four cases. Am J Surg Pathol 2003; 27 (2): 242-247.
18. Nayar R, Siriaunkgul S, Robbins KM, Microinvasion in low malignant potential tumors of the ovary. Hum Pathol 1996; 27 (6): 521-527.
19. Nomura K, Aizawa S,. Clinicopathologic and mucin histochemical analyses of 90 cases of ovarian mucinous borderline tumors of intestinal and müllerian types. Pathol Int 1996; 46 (8): 575-580.
20. Rodriguez IM, Irving JA, Prat J,. Endocervical-like mucinous borderline tumors of the ovary: a clinicopathologic analysis of 31 cases. Am J Surg Pathol 2004; 28 (10): 1311-1318.
21. Wu CH, Mao TL, Vang R, Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A. Int J Gynecol Pathol 2012; 31 (4): 297-303.
22. Avril S, Hahn E, Specht K, Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome. Gynecol Oncol 2012; 127 (3): 516-524.
23. Fukunaga M, Nomura K, Ishikawa E, Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology 1997; 30 (3): 249-255.
24. Yasunaga M, Ohishi Y, Oda Y, Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors. Hum Pathol 2009; 40 (7): 965-974.
25. Siriaunkgul S, Robbins KM, McGowan L, Ovarian mucinous tumors of low malignant potential: a clinicopathologic study of 54 tumors of intestinal and müllerian type. Int J Gynecol Pathol 1995; 14 (3): 198-208.
26. Korourian S, McKenney J, de Las Casas LE,. Endocervical-like mucinous borderline tumors. Am J Surg Pathol 2005; 29 (3): 424. author reply 424.
27. Lim S, Kim JY, Park K, Mullerianosis of the mesosalpinx: a case report. Int J Gynecol Pathol 2003; 22 (2): 209-212.
28. Kataoka M, Togashi K, Koyama T, MR imaging of müllerian mucinous borderline tumors arising from endometriotic cysts. J Comput Assist Tomogr 2002; 26 (4): 532-537.
29. Matsubayashi RN, Matsuo Y, Nakazono T, Magnetic resonance imaging manifestations of ovarian mullerian mixed epithelial borderline tumors: imaging and histologic features in comparison with mullerian mucinous borderline tumors. J Comput Assist Tomogr 2015; 39 (2): 276-280.
30. Song T, Choi CH, Lee YY, Endocervical-like versus intestinal-type mucinous borderline ovarian tumors: a large retrospective series focusing on the clinicopathologic characteristics. Gynecol Obstet Invest 2013; 76 (4): 241-247.
31. Lee KR, Nucci MR,. Ovarian mucinous and mixed epithelial carcinomas of mullerian (endocervical-like) type: a clinicopathologic analysis of four cases of an uncommon variant associated with endometriosis. Int J Gynecol Pathol 2003; 22 (1): 42-51.
32. Zannoni GF, Vellone VG, Chiarello G,. Borderline mucinous endocervical tumor as a link between the endometriotic cyst and ovarian primary squamous cell carcinoma. Int J Gynecol Pathol 2011; 30 (4): 396-397.
33. Ball NJ, Robertson DI, Duggan MA, Intestinal differentiation in ovarian mucinous tumours. Virchows Arch A Pathol Anat Histopathol 1990; 417 (3): 197-201.
34. Nonaka D, Chiriboga L, Soslow RA,. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol 2008; 32 (10): 1566-1571.
35. Lin X, Lindner JL, Silverman JF, Intestinal type and endocervical-like ovarian mucinous neoplasms are immunophenotypically distinct entities. Appl Immunohistochem Mol Morphol 2008; 16 (5): 453-458.
36. Rutgers JL, Bell DA,. Immunohistochemical characterization of ovarian borderline tumors of intestinal and mullerian types. Mod Pathol 1992; 5 (4): 367-371.
37. Shiohara S, Shiozawa T, Shimizu M, Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis. Cancer 1997; 80 (5): 908-916.
38. Vang R, Gown AM, Barry TS, Ovarian atypical proliferative (borderline) mucinous tumors: gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive. Int J Gynecol Pathol 2006; 25 (1): 83-89.
39. Halimi SA, Maeda D, Shinozaki-Ushiku A, Claudin-18 overexpression in intestinal-type mucinous borderline tumour of the ovary. Histopathology 2013; 63 (4): 534-544.
40. Ronnett BM, Kajdacsy-Balla A, Gilks CB, Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior. Hum Pathol 2004; 35 (8): 949-960.
41. Hart WR,. Mucinous tumors of the ovary: a review. Int J Gynecol Pathol 2005; 24 (1): 4-25.
42. Black JD, Altwerger GH, Ratner E, Management of borderline ovarian tumors based on patient and tumor characteristics. Gynecol Obstet Invest 2015 Jun 6 [Epub ahead of print].
43. LaGrenade A, Silverberg SG,. Ovarian tumors associated with atypical endometriosis. Hum Pathol 1988; 19 (9): 1080-1084.
44. Czernobilsky B, Morris WJ,. A histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes. Obstet Gynecol 1979; 53 (3): 318-323.
45. Taylor J, McCluggage WG,. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm. Am J Surg Pathol 2015; 39 (7): 983-992.
46. D'Angelo E, Dadmanesh F, Pecorelli S, Squamous cell carcinoma of the ovary arising from a mucinous cystic tumor of endocervical (müllerian) type. Int J Gynecol Pathol 2010; 29 (6): 529-532.
47. Kikkawa F, Kawai M, Tamakoshi K, Mucinous carcinoma of the ovary. Clinicopathologic analysis. Oncology 1996; 53 (4): 303-307.
48. Kolasa IK, Rembiszewska A, Janiec-Jankowska A, PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations. Gynecol Oncol 2006; 103 (2): 692-697.
49. McCluggage WG, Maxwell P, Veenstra H, Monoclonal antibody SM047 as an immunohistochemical marker of ovarian adenocarcinoma. Histopathology 2001; 38 (6): 542-549.
50. Yasuoka H, Tsujimoto M, Fujita S, Monoclonality of composite large cell neuroendocrine carcinoma and mucinous epithelial tumor of the ovary: a case study. Int J Gynecol Pathol 2009; 28 (1): 55-58.
51. Available at: http://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf. Accessed Jan 6, 2016.
52. Dutt N, Berney DM,. Clear cell carcinoma of the ovary arising in a mucinous cystadenoma. J Clin Pathol 2000; 53 (12): 938-939.
53. Nakamura E, Sato Y, Moriguchi S, Ovarian seromucinous borderline tumor and clear cell carcinoma: an unusual combination. Case Rep Obstet Gynecol 2015; 2015: 690891.
54. Shang HS, Chao TK, Wu GZ, A rare case of the coexistence of ovarian clear cell carcinoma, mucinous cystadenoma, and endometriosis in the same ovary. Eur J Gynaecol Oncol 2011; 32 (6): 677-679.
55. Uddin Z, Yaqoob N, Kayani N, Clear cell carcinoma of ovary with associated mucinous cystadenoma and endometriosis. J Pak Med Assoc 2007; 57 (7): 373-375.
56. Wani Y, Notohara K,. Ovarian clear cell carcinoma arising in a mucinous cystadenoma. Int J Gynecol Pathol 2009; 28 (6): 584-588.
57. Ohishi Y, Kurihara S, Aman M, "Piling up" clear cells in müllerian-type mucinous and mixed cell-type borderline tumor do not represent concomitant clear cell neoplasms. Hum Pathol 2012; 43 (10): 1618-1626.
58. Huang W, Cheng X, Ji J, The application value of HNF-1β transcription factor in the diagnosis of ovarian clear cell carcinoma. Int J Gynecol Pathol 2016; 35 (1): 66-71.
59. Scully RE, Young RH, Clement PB,. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament. Washington, D.C. 1998.
60. Baergen RN, Rutgers JL,. Mural nodules in common epithelial tumors of the ovary. Int J Gynecol Pathol 1994; 13 (1): 62-72.
61. Provenza C, Young RH, Prat J,. Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcomalike mural nodules. Am J Surg Pathol 2008; 32 (3): 383-389.
62. Kim SK, Cho NH,. HER2-positive mucinous adenocarcinomas of the ovary have an expansile invasive pattern associated with a favorable prognosis. Int J Clin Exp Pathol 2014; 7 (7): 4222-4230.
63. Park KJ, Bramlage MP, Ellenson LH, Immunoprofile of adenocarcinomas of the endometrium, endocervix, and ovary with mucinous differentiation. Appl Immunohistochem Mol Morphol 2009; 17 (1): 8-11.
64. Rutgers JL, Baergen RN,. Mucin histochemistry of ovarian borderline tumors of mucinous and mixed-epithelial types. Mod Pathol 1994; 7 (8): 825-828.
65. Solakoglu Kahraman D, Diniz G, Sayhan S, Differences in the ARID-1 alpha expressions in squamous and adenosquamous carcinomas of uterine cervix. APMIS 2015; 123 (10): 847-850.
66. Biegel JA, Busse TM, Weissman BE,. SWI/SNF Chromatin Remodeling Complexes and Cancer. Am J Med Genet C Semin Med Genet 2014; 166C (3): 350-366.
67. Maeda D, Shih I-M,. Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms. Adv Anat Pathol 2013; 20 (1): 45-52.
68. Wiegand KC, Shah SP, Al-Agha OM, ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 2010; 363 (16): 1532-1543.
69. Wu RC, Wang TL, Shih IeM,. The emerging roles of ARID1A in tumor suppression. Cancer Biol Ther 2014; 15 (6): 655-664.
70. Katagiri A, Nakayama K, Rahman MT, Frequent loss of tumor suppressor ARID1A protein expression in adenocarcinomas/adenosquamous carcinomas of the uterine cervix. Int J Gynecol Cancer 2012; 22 (2): 208-212.
71. Obata K, Morland SJ, Watson RH, Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res 1998; 58 (10): 2095-2097.
72. Mok SC, Bell DA, Knapp RC, Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res 1993; 53 (7): 1489-1492.
73. Mayr D, Hirschmann A, Löhrs U, KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants. Gynecol Oncol 2006; 103 (3): 883-887.
74. Ichikawa Y, Nishida M, Suzuki H, Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors. Cancer Res 1994; 54 (1): 33-35.
75. Gemignani ML, Schlaerth AC, Bogomolniy F, Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma. Gynecol Oncol 2003; 90 (2): 378-381.
76. Chao WR, Lee MY, Ruan A, Assessment of HER2 status using immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) techniques in mucinous epithelial ovarian cancer: a comprehensive comparison between toga biopsy method and toga surgical specimen method. PloS One 2015; 10 (11): e0142135.
77. Mostoufizadeh M, Scully RE,. Malignant tumors arising in endometriosis. Clin Obstet Gynecol 1980; 23 (3): 951-963.
78. Sampson JA,. ENdometrial carcinoma of the ovary, arising in endometrial tissue in that organ. Arch Surg 1925; 10 (1): 1-72.
79. Scott RB,. Malignant changes in endometriosis. Obstet Gynecol 1953; 2 (3): 283-289.
80. Hendrickson MR, Kempson RL,. Endometrial epithelial metaplasias: proliferations frequently misdiagnosed as adenocarcinoma. Report of 89 cases and proposed classification. Am J Surg Pathol 1980; 4 (6): 525-542.
81. Kawamura K, Kaneki E, Ogawa S, Primary uterine müllerian mucinous borderline tumor (MMBT) associated with adenomyosis: a case report. Int J Gynecol Pathol 2014; 33 (2): 146-150.
82. Srinivasan R, Gupta N, Gupta I,. Recurrent endocervical-like mucinous borderline tumor (ELMBT) arising in a case of long-standing endometriosis-a case report. Indian J Pathol Microbiol 2006; 49 (2): 277-278.
83. Yeo DM, Rha SE, Byun JY, MR imaging findings of extraovarian endocervical mucinous borderline tumors arising from pelvic endometriosis. Korean J Radiol 2013; 14 (6): 918-922.
84. Clement PB, Young RH,. Endocervicosis of the urinary bladder. A report of six cases of a benign müllerian lesion that may mimic adenocarcinoma. Am J Surg Pathol 1992; 16 (6): 533-542.
85. Guan H, Rosenthal DL, Erozan YS,. Mullerianosis of the urinary bladder: report of a case with diagnosis suggested in urine cytology and review of literature. Diagn Cytopathol 2012; 40 (11): 997-1001.
86. Mukonoweshuro P, McCluggage WG,. Endocervicosis involving axillary lymph nodes: first case report. Int J Gynecol Pathol 2014; 33 (6): 620-623.
87. Wong AK, Seidman JD, Barbuto DA, Mucinous metaplasia of the fallopian tube: a diagnostic pitfall mimicking metastasis. Int J Gynecol Pathol 2011; 30 (1): 36-40.